Cellectis S.A. (EPA:ALCLS)
France · Delayed Price · Currency is EUR 1.238
-0.113 (-8.36%)
Nov 12, 2026, 9:24 AM CET
Cellectis Market Cap
Cellectis has a market cap or net worth of €90 million as of November 11, 2026. It is the 24,412th most valuable company in the world and the 293rd biggest in France. Its market cap has decreased by 56.49% in one year.
Market Cap
90.00M
Enterprise Value
14.43M
Revenue
55.86M
Global Rank
Country Rank
#293 France
PE Ratio
n/a
ChartMarket Cap Chart
Since February 7, 2007, Cellectis's market cap has decreased from 100.59M to 90.00M, a decrease of -10.53%. That is a compound annual growth rate of -0.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 76.26M | -74.87% |
| Dec 31, 2025 | 303.40M | 158.68% |
| Dec 31, 2024 | 117.29M | -40.86% |
| Dec 29, 2023 | 198.32M | 118.98% |
| Dec 30, 2022 | 90.57M | -73.23% |
| Dec 31, 2021 | 338.35M | -67.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Valerio Therapeutics Société anonyme | 245.73M |
| Transgene | 202.13M |
| Innate Pharma | 125.56M |
| Sensorion | 89.96M |
| ABIONYX Pharma | 67.32M |
| Adocia | 58.74M |
| THX Pharma Société Anonyme | 47.34M |
| OSE Immunotherapeutics | 40.48M |